Answers are grounded in this paper and cite their sources.
Analyzes outcomes in oral cavity cancer patients post-surgery based on ENE and PNI status, suggesting treatment adjustments.
Background The AJCC 8th edition recommends subclassifying extranodal extension (ENE) and perineural invasion (PNI) in oral cavity squamous cell carcinoma (OCSCC), though their prognostic relevance remains uncertain. Methods Post‐operative OCSCC patients (2019–2024) receiving adjuvant radiotherapy or chemoradiotherapy with documented ENE and/or PNI were retrospectively analyzed. ENE (microscopic [miENE] vs. macroscopic [maENE]) and PNI (intratumoral [IPNI] vs. extratumoral [EPNI]) were correlated with disease‐free survival (DFS), overall survival (OS), and failure patterns using multivariate Cox models. Results Among 410 patients (median follow‐up: 33 months), 3‐year DFS and OS were 45.6% and 53.2%. ENE subtyping did not impact DFS or OS. EPNI independently predicted inferior DFS (43.3% vs. 49.5%, p = 0.019) and OS (50.2% vs. 57.9%, p = 0.02). Combined EPNI, ENE, and lymph‐node ratio > 0.05 identified a very high‐risk subgroup. Conclusion ENE subclassification lacked prognostic significance. EPNI predicted worse outcomes and, with ENE or high lymph node ratio, defines an aggressive phenotype warranting treatment intensification.
No takes yet. Share an insight, caveat, or question.
Nanda et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: